Skip to main content
. Author manuscript; available in PMC: 2016 Sep 24.
Published in final edited form as: J Med Chem. 2015 Sep 10;58(18):7485–7500. doi: 10.1021/acs.jmedchem.5b01005

Table 4.

mGlu3 NAM and mGlu5 SAR of 5-Fluoropyridin-2-yl Ether Analogues 55–72

graphic file with name nihms-766653-f0012.jpg
no. R mGlu3 pIC50 (± SEM)a mGlu3 IC50 (nM)a % Glu Max (± SEM)a,b mGlu5 activityc mGlu5 pEC50 (± SEM)c mGlu5 EC50 (nM)c % Glu Max (± SEM)b,c
55 2-fluorophenyl 6.79 ± 0.17 162 1.53 ± 0.12 NAMf <5.0 >10000 29.1 ± 7.3
56 3-fluorophenyl 6.72 ± 0.08 192 1.44 ± 0.38 NAM 5.56 ± 0.24 2720 9.71 ± 5.78
57 2-chlorophenyl 6.85 ± 0.16 141 1.37 ± 0.72 NAM 6.00 ± 0.25 1010 8.78 ± 5.29
58 3-chlorophenyl 6.84 ± 0.10 145 2.30 ± 0.17 NAMe 5.73 ± 0.24 1850 19.2 ± 10.0
59 4-chlorophenyl 6.71 ± 0.13 197 2.17 ± 0.40 PAM 6.44 ± 0.03 364 51.6 ± 7.7
60 2-methylphenyl 6.46 ± 0.06 346 1.72 ± 0.16 NAMf <5.0d >10000d 35.8d
61 3-methylphenyl 6.67 ± 0.15 216 1.93 ± 0.56 NAMf <5.0 >10000 36.6 ± 8.7
62 4-methylphenyl 6.57 ± 0.03 269 1.04 ± 0.45 NAMf <5.0 >10000 54.8 ± 9.4
63 2-methoxyphenyl 6.47 ± 0.10 339 1.49 ± 0.60 NAM 6.52 ± 0.17 301 3.28 ± 0.45
64 3-methoxyphenyl 6.70 ± 0.06 198 1.02 ± 0.12 NAMf <5.0 >10000 59.7 ± 6.1
65 4-methoxyphenyl 6.49 ± 0.10 320 1.23 ± 0.38 PAM 5.86 ± 0.05 1380 32.3 ± 5.2
66 2,3-difluorophenyl 6.73 ± 0.16 184 2.15 ± 0.33 NAMe 5.68 ± 0.20 2110 21.0 ± 10.6
67 2,5-difluorophenyl 6.91 ± 0.11 123 2.62 ± 0.47 NAMf <5.0 >10000 18.8 ± 6.1
68 2,6-difluorophenyl 6.74 ± 0.08 181 1.49 ± 0.17 NAMe 5.91d 1230d 50.8d
69 pyridin-2-yl 6.04 ± 0.05 915 0.96 ± 0.63 NAM 5.45 ± 0.04 3520 3.71 ± 0.47
70 pyridin-3-yl 6.36 ± 0.13 436 0.64 ± 0.70 NAMf <5.0 >10000 46.3 ± 2.9
71 pyridin-4-yl 6.05 ± 0.04 881 0.77 ± 0.44 <4.5 >30000
72 5-fluoropyridin-2-yl 6.46 ± 0.07 349 1.31 ± 0.11 NAM 5.01 ± 0.13 9740 7.0 ± 2.5
a

Calcium mobilization mGlu3 assay; values are average of n ≥ 3.

b

Amplitude of response in the presence of 30 μM test compound as a percentage of maximal response (100 μM glutamate); average of n ≥ 3.

c

Calcium mobilization mGlu5 assay; values are average of n ≥ 3.

d

Average of n = 2.

e

Partial NAM; CRC plateaus above 10% glutamate maximum.

f

Weak activity; CRC does not plateau.

HHS Vulnerability Disclosure